
UT San Antonio study finds endometrial cancer rates highest in San Antonio region
October 14, 2026
A new study published in July in Cancer Epidemiology, led by scientists at The University of Texas at San Antonio Health Science Center and the National Cancer Institute, found that the Upper-South region of Texas, which includes San Antonio and Bexar County, had the highest hysterectomy-corrected incidence of endometrial cancer in Texas and the largest increase over time.

Cross-institutional pilot grant supports study of personalized approach to diabetes prevention
September 2, 2026
A new cross-institutional research study between The University of Texas at San Antonio and Texas State University aims to better understand how diet, genetics and physical activity interact to influence diabetes risk.
UT San Antonio researchers uncover how liver’s internal clock may influence metabolism
July 29, 2026
Researchers at The University of Texas at San Antonio (UT San Antonio) have uncovered a treasure trove of information about hundreds of proteins released by the liver and how the timing of their release may affect bodily processes. A recent study, publ …
GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
June 25, 2026
Colton Frisco Jones, MD, a 2nd-year fellow at the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio N …

UT San Antonio awarded $44 million NIH contract to advance landmark RURAL Cohort Study
April 30, 2026
The University of Texas at San Antonio has been awarded a five-year, $44 million contract from the National Heart, Lung, and Blood Institute of the National Institutes of Health for a landmark study focused on persistent health challenges in the rural South.

Widely used metabolic drugs may help curb rising colorectal cancer in younger adults
March 2, 2026
A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.

UT Health San Antonio leads $4 million study on glucagon’s role in diabetes, obesity
November 11, 2025
The first-of-its-kind study will examine how glucagon contributes to insulin secretion, glucose regulation and energy balance in people with obesity who have or have not undergone bariatric surgery.
Pilot study: Branched-chain amino acids may help physical, mental fatigue in older adults
October 2, 2025
It is often said that exercise is the best medicine, but for many older adults, it can be a prescription that is increasingly difficult to take. Age-related physical and mental health challenges frequently make regular activity hard to sustain. …
Scientists pinpoint early warning stage before prediabetes
September 4, 2025
iStock photo A new study from The University of Texas at San Antonio Health Science Center indicates that changes in the body that lead to Type 2 diabetes occur long before current diagnostic thresholds for prediabetes are met. The first-of-its-kind st …
First national review of anti-aging compounds
July 28, 2025
The first comprehensive review of the NIH’s Interventions Testing Program was published in July 2025. Study finds rapamycin shows greatest longevity effect in 20-year NIH Interventions Testing Program The first comprehensive review of two decade …
